Thompson Street Capital Partners Portfolio Company Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes to Expand Manufacturing Capabilities

Acquisition contributes to long-term growth strategy of accelerating commercialization of innovative labeling and detection technologies

Thompson Street Capital Partners (“TSCP”), a private equity firm based in St. Louis, MO, today announced that its portfolio company Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, has acquired Click Chemistry Tools, a manufacturer of click chemistry linkers and labeling reagents, and Fluoroprobes, a leader in fluorescent probes and dyes. These acquisitions will expand Vector Laboratories’ manufacturing and bioconjugation capabilities to better serve partners across biopharma and the life sciences. Terms of the transaction were not disclosed.

“Vector Laboratories is excited about these acquisitions because it's the first to contribute to our long-term strategic vision of accelerating the pace of protein detection innovation,” says CEO of Vector Laboratories Lisa V Sellers, PhD. “This is an investment to expand our capabilities and technology set for labeling, detecting, and conjugating products for our current customers and expands our ability to serve broader industrial segments such as biopharma and therapeutics.”

Scottsdale, AZ-based Click Chemistry Tools was founded a decade ago to create novel cross-linking and labeling reagents using the most up-to-date research. Its products are used to advance drug discoveries, therapeutic approaches, and diagnostic techniques of many prestigious research and academic institutions nationally and worldwide. Fluoroprobes provides expertise in fluorescent probes and dyes to reliably manufacture the same compounds as larger companies, guaranteeing the quality and reproducibility of all its products.

“The combination of Vector Laboratories, Click Chemistry Tools and Fluoroprobes will further our effort to create a truly unique offing in the protein detection space,” said J.C. Wetzel, Director at TSCP. “We are thrilled to be partnering with Andrei Polukhtin, founder and former CEO of Click Chemistry Tools and Fluoroprobes, and his team to leverage what they have already built across the Vector Laboratories ecosystem.”

About Thompson Street Capital Partners

Thompson Street Capital Partners (TSCP) is a St. Louis-based private equity firm focused on investing in founder-led middle market businesses. We have acquired more than 150 companies in the Healthcare & Life Science Services, Software & Technology Services and Business Services & Engineered Products sectors and have managed more than $4.5 billion since being founded in 2000. TSCP partners with management teams to increase value by accelerating growth, both organically and via complementary acquisitions.

About Vector Laboratories

Vector Laboratories empowers scientific advances with innovative proteomic and glycomic research solutions. Supporting industries worldwide for 45 years and counting, Vector Laboratories is a trusted manufacturing partner with unmatched technical expertise and a culture of service. Customers rely on Vector Laboratories’ immunofluorescence, immunohistochemistry, glycobiology and bioconjugation products and custom manufacturing capabilities to move science forward, with impact. Vector Laboratories’ market-tested product portfolio provides the critical tools researchers need to precisely visualize and study tissues and cells, and to ultimately tackle today’s biggest healthcare challenges. The company’s products and technologies have been cited in more than 350,000 peer-reviewed publications and its catalog and custom products are relied upon by laboratories around the world. Headquartered in Newark, CA, Vector Laboratories includes a global network of more than 40 distributors. For more information about Vector Laboratories, please visit: www.vectorlabs.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005120/en/